Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ADHD Advisory Committee Wants FDA-Defined Standards Before Clearing Abuse-Deterrent Stimulant Label
Oct 12 2020
•
By
Sarah Karlin-Smith
FDA needs clearer standards for abuse-deterrent stimulants, its advisors say • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers